Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Trending
Portfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Log Out
NXTC
Stock Latest News
The Fly
NextCure announces data from Phase 1b trial evaluating NC410
4d ago
NXTC
Premium
Press Releases
NextCure Presented Results of the Phase 1b Study of NC410 in Combination with Pembrolizumab at ESMO 2024
4d ago
NXTC
Premium
The Fly
NextCure reports Q2 EPS (55c), consensus (38c)
2M ago
NXTC
Premium
Press Releases
NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results
2M ago
NXTC
Premium
Press Releases
NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
3M ago
NXTC
Premium
The Fly
NextCure presents Phase 1b data on NC410 and pembrolizumab combo at ASCO
4M ago
NXTC
Premium
Press Releases
NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
4M ago
NXTC
Premium
The Fly
NextCure treatment of osteogenesis imperfecta granted orphan designation
4M ago
NXTC
Premium
The Fly
NextCure reports Q1 EPS (61c), consensus (46c)
5M ago
NXTC
Premium
Press Releases
NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
5M ago
NXTC
Premium
Press Releases
NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
5M ago
NXTC
Premium
The Fly
NextCure and LCB present data on B7-H4 antibody drug conjugate at AACR
5M ago
NXTC
Premium
Press Releases
NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
5M ago
NXTC
Premium
The Fly
NextCure appoints Rakesh Dixit to Scientific Advisory Board
6M ago
NXTC
Premium
Press Releases
NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
6M ago
NXTC
Premium
Press Releases
NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
6M ago
NXTC
Premium
Company Announcements
NextCure Inc to Engage with Investors in Informal Talks
6M ago
8K
NXTC
Premium
The Fly
NextCure restructures operations, reduces workforce by 37%
6M ago
NXTC
Premium
The Fly
NextCure announces intention to partner assets
6M ago
NXTC
Premium
Press Releases
NextCure Provides Business Update and Reports Full Year 2023 Financial Results
6M ago
NXTC
Premium
The Fly
NextCure to prioritize NC410 combo, LNCB74 in 2024
6M ago
NXTC
Premium
Press Releases
NextCure Provides Business Update and Reports Full Year 2023 Financial Results
6M ago
NXTC
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
